Bacterial antimicrobial resistance (AMR) was associated with 4.95 million deaths in 2019, of which 1.27 million were directly attributable to resistance.

Original statement

4.95 مليون وفاة مرتبطة بمقاومة المضادات في عام واحد، منها 1.27 مليون منسوبة مباشرة إلى المقاومة البكتيرية

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Bacterial antimicrobial resistance (AMR) was associated with 4.95 million deaths in 2019, of which 1.27 million were directly attributable to resistance.

Origin

Source status

Archive editors

Attribution

Archive editors (eltayebat.com)

Origin

https://eltayebat.com/rule/antibiotic-overuse/

Attribution uncertainty

Archive editorial narrative and featured-study cards, written by the archive operators; study selection is the archive's, not necessarily Elawady's.

Claimed mechanism

Resistant infections.

Claimed health effect

Deaths.

Population concerned

Global

Geographic restriction by Elawady

none found

Scientific assessment

True – The statement is supported by robust evidence.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

AMR burden figures.

2. What is demonstrably correct?

4.95 million (95% UI 3.62-6.57) associated and 1.27 million (0.911-1.71) attributable deaths in 2019 (A-ABX-18). The GBD 2021 analysis re-estimated 2019 at 4.94 million (4.43-5.45) associated and 1.20 million (1.05-1.35) attributable deaths, and gives 4.71 million associated and 1.14 million attributable for 2021; forecast 1.91 million attributable and 8.22 million associated deaths in 2050 (I-ABX-01). WHO Eastern Mediterranean Region (includes Egypt): 380,000 associated and 92,800 attributable deaths in 2021 (I-ABX-02).

3. What is wrong or exaggerated?

Nothing wrong with the numbers; they are model estimates, not counts.

4. What remains unclear?

Uncertainty in data-poor countries.

5. Which studies support it?

A-ABX-18, I-ABX-01, I-ABX-02.

6. Which studies contradict it?

None. The later GBD 2021 analysis gives slightly different figures for the same year 2019 (1.20 instead of 1.27 million attributable; 4.94 instead of 4.95 million associated) and lower figures for 2021 (I-ABX-01); the claim's figures correspond to the earlier publication and remain broadly consistent. All figures are model estimates with uncertainty intervals.

7. What applies to Germany and Europe?

Australasia lowest attributable rate (6.5/100,000), western sub-Saharan Africa highest (27.3/100,000) in 2019 (A-ABX-18).

8. What is known about Egypt?

In 2019 the attributable rate for North Africa and Middle East was 11.2 per 100,000 (Table 2 of A-ABX-18, read via PMC web page).

9. What practical conclusion is appropriate?

AMR is a major threat; the GBD authors also stress that better access to appropriate antibiotics could avert many deaths (I-ABX-01).

Assessment details

Rationale for certainty of evidence

Correctly reported from GBD modelling; estimates have wide uncertainty intervals and are model-based, especially for data-poor regions. The later GBD 2021 analysis re-estimated 2019 at 4.94 million associated and 1.20 million attributable deaths, and gives 4.71 million and 1.14 million for 2021 (I-ABX-01).

Source quality

Large systematic modelling study (Lancet).

Regional transferability

Global; highest burden in low-resource settings.

Individual exceptions

Not applicable.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

Researchers estimated that in 2019 about 1.27 million deaths worldwide were directly caused by antibiotic-resistant bacteria. A newer analysis estimated 1.14 million for 2021. These are model estimates with some uncertainty. The same researchers say that better access to the right antibiotics is part of the solution.

Studies on this claim

Regional context

Germany / EU

Australasia lowest attributable rate (6.5/100,000), western sub-Saharan Africa highest (27.3/100,000) in 2019 (A-ABX-18).

Egypt

In 2019 the attributable rate for North Africa and Middle East was 11.2 per 100,000 (Table 2 of A-ABX-18, read via PMC web page).

What applies in my country?

General scientific assessment

True Correctly reported.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.. Antimicrobial Resistance Collaborators. Lancet 2022 · PMID 35065702 · DOI 10.1016/S0140-6736(21)02724-0
2. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.. GBD 2021 Antimicrobial Resistance Collaborators. Lancet 2024 · PMID 39299261 · DOI 10.1016/S0140-6736(24)01867-1
3. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050.. EMR Antimicrobial Resistance Collaborators. Lancet Public Health 2025 · PMID 41082884 · DOI 10.1016/S2468-2667(25)00201-4